Hypertension in elderly patients: Recommended systolic targets are not evidence based;Hypertension chez les patients ages: Les seuils systoliques recommandés ne sont pas fondés scientifiquement

Canadian Family Physician

Volumn 59, Issue 1, 2013, Pages

  Allen, Michael ^a   Kelly, Kim ^b   Fleming, Isobel ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; EFONIDIPINE; VALSARTAN;

AGED; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; NOTE; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; SYSTOLE;

EID: 84873860068     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (13)

1. Chan BT, Schultz SE. Supply and utilization of general practitioner and family physician services in Ontario. ICES investigative report. Toronto, ON: Institute for Clinical Evaluative Sciences; 2005. Available from: www.ices.on.ca/file/FP-GP-aug08-FINAL.pdf. Accessed 2012 May 5.
2. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011;123(21):2434-506. Epub 2011 Apr 25.
3. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993;153(5):598-615.
4. Franklin SS. Systolic blood pressure: it's time to take control. Am J Hypertens 2004;17(12 Pt 2):49S-54S.
5. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009;(4):CD000028.
6. Verdecchia P, Reboldi G, Angeli F, Gattobigio R, Bentivoglio M, Thijs L, et al. Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension 2005;46(2):386-92. Epub 2005 Jul 11.
7. Hypertension Canada [website]. 2011 CHEP recommendations for the management of hypertension. Markham, ON: Canadian Hypertension Education Program; 2011. Available from: http://hypertension.ca/images/stories/dls/2011gl/ FullCHEPRecommendations-EN-2011.pdf. Accessed 2012 Dec 4.
8. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27(11):2121-58.
9. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study. Hypertension 2010;56(2):196-202. Epub 2010 Jun 7.
10. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008;31(12):2115-27.
11. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358(18):1887-98. Epub 2008 Mar 31.
12. Mazza A, Ramazzina E, Cuppini S, Armigliato M, Schiavon L, Rossetti C, et al. Antihypertensive treatment in the elderly and very elderly: always "the lower, the better?" Int J Hypertens 2012;2012:590683. Epub 2011 Sep 22.
13. Angeli F, Reboldi G, Verdecchia P. "The lower the BP the better" paradigm in the elderly: vanished by VALISH? Hypertension 2010;56(2):182-4. Epub 2010 Jun 7.